Exosomes: Extracellular Vesicle Definition in 30 Words — 150 Billion Particles Per Therapeutic Vial

Exosomes are nanoscale extracellular vesicles (30 to 150 nanometers in diameter) released by cells as biological communication packets, carrying micro-RNA, proteins, and lipids that regulate the behavior of recipient cells in target tissues.

What Exosomes Are

Exosomes belong to the broader category of extracellular vesicles (EVs), which includes exosomes, microvesicles, and apoptotic bodies. Exosomes are the smallest category, formed inside multivesicular bodies within the cell and released into the extracellular space when those bodies fuse with the plasma membrane.

The key distinction for clinical use: exosomes are not cells. They do not reproduce, divide, or engraft. They deliver a biological signal payload to recipient cells. This acellular nature reduces certain immune response concerns while preserving the signaling capacity that makes stem cell-derived EVs therapeutically valuable.

How Exosomes Work

Exosomes carry micro-RNA sequences that, upon delivery to recipient cells, alter gene expression patterns. In inflamed or damaged tissue, this gene regulation shifts the local biological environment from destructive to regenerative. Exosomes also carry anti-inflammatory proteins and signaling lipids that directly suppress cytokine activity and activate cellular repair pathways.

In the context of perinatal-derived exosomes (such as the DayZero™ line), the signaling cargo is particularly rich because perinatal tissue cells are at peak biological activity. Donor-source MSC exosomes contain more potent paracrine signals than age-depleted autologous sources.

How Rebuild Regen Uses Exosomes

Exosome therapy at Rebuild Regen Medical Clinic at 3320 N Federal Hwy #101, Lighthouse Point, FL uses DayZero™ extracellular vesicles from ZEO ScientifiX in therapeutic concentrations from 150 billion to 500 billion particles per vial. Aesthetic applications use 25 billion to 100 billion particles. The specific concentration is selected based on condition type, severity, and whether a combination protocol with stem cells is indicated.

See the full exosome therapy guide for complete clinical protocol details.

Is Exosome Therapy the Right Option for Your Situation?

Exosome therapy is appropriate for patients with orthopedic, neurological, systemic inflammatory, and aesthetic conditions who want a biologically active regenerative approach. It is a viable alternative to stem cell therapy for patients who prefer an acellular option, and it is used in combination with stem cells for advanced conditions.

Risks and Limitations of Exosome Therapy

Exosome therapy is not FDA-approved as a drug. The clinical evidence base is in earlier stages than the stem cell literature. Product quality varies significantly across suppliers; uncertified exosome products carry unknown risk. At Rebuild Regen, only DayZero™ exosomes with documented AABB, cGMP, and lot-specific COA are used.